Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.clim.2021.108814 http://scihub22266oqcxt.onion/10.1016/j.clim.2021.108814 34343708!8325385!34343708     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Immunol 2021 ; 230 (ä): 108814 Nephropedia Template TP {{tp|p=34343708|t=2021. Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection |pdf=|usr=}}{{34343708}} gab.com Text Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection JO: Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34343708 #FOAvip Better understanding of antibody responses against SARS-CoV-2 after natural infection might provide valuable insights into the future implementation of vaccination policies. Longitudinal analysis of IgG antibody titers was carried out in 32 recovered COVID-19 patients based in the Umbria region of Italy for 14 months after Mild and Moderately-Severe infection.Two FDA-approved immunoassays against SARS-CoV-2 Nucleocapsid protein (NCP) and anti-spike-receptor binding domain (S-RBD) were used for sequential serological tests at different time points. The demographics,clinical history and symptom profile associated with the magnitude and longevity of antibody responses were also analyzed. Anti-S-RBD IgG persisted in 96.8% (31 of 32) subjects at 14 months. Patients reporting loss of smell and taste during the clinical course of the disease developed significantly higher antibody titers. Anti-NCP IgG seronegative patients(n=7) at 10 months, tested positive for anti-S-RBD IgG at 12,13 and 14 months emphasizing on a higher false-negative rate for NCP protein-based antibody assays. This study also highlights the importance of adopting specific immunoassays for routine estimation of antibody titers and the decreased rate of re-infections in recovered patients. Twit Text FOAVip Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection ????Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34343708 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34343708 #FOAvip English Wikipedia <ref>{{Cite pmid|34343708}}</ref> Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection #MMPMID34343708 Dehgani-Mobaraki P; Zaidi AK; Yadav N; Floridi A; Floridi E Clin Immunol 2021[Sep]; 230 (ä): 108814 PMID34343708show ga Better understanding of antibody responses against SARS-CoV-2 after natural infection might provide valuable insights into the future implementation of vaccination policies. Longitudinal analysis of IgG antibody titers was carried out in 32 recovered COVID-19 patients based in the Umbria region of Italy for 14 months after Mild and Moderately-Severe infection.Two FDA-approved immunoassays against SARS-CoV-2 Nucleocapsid protein (NCP) and anti-spike-receptor binding domain (S-RBD) were used for sequential serological tests at different time points. The demographics,clinical history and symptom profile associated with the magnitude and longevity of antibody responses were also analyzed. Anti-S-RBD IgG persisted in 96.8% (31 of 32) subjects at 14 months. Patients reporting loss of smell and taste during the clinical course of the disease developed significantly higher antibody titers. Anti-NCP IgG seronegative patients(n=7) at 10 months, tested positive for anti-S-RBD IgG at 12,13 and 14 months emphasizing on a higher false-negative rate for NCP protein-based antibody assays. This study also highlights the importance of adopting specific immunoassays for routine estimation of antibody titers and the decreased rate of re-infections in recovered patients. |Adult[MESH] |Antibodies, Viral/*blood[MESH] |COVID-19 Vaccines/administration & dosage/*immunology[MESH] |COVID-19/blood/*immunology/prevention & control/*virology[MESH] |Comorbidity[MESH] |Female[MESH] |Humans[MESH] |Immunoglobulin G/*blood[MESH] |Immunoglobulin M/blood[MESH] |Longitudinal Studies[MESH] |Male[MESH] |Middle Aged[MESH] |Pilot Projects[MESH] |SARS-CoV-2/*immunology[MESH]Longitudinal observation of antibody responses for 14 months after SAR(epmc).pdf DeepDyve Pubget Overpricing